Register
|
Login
The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
NEWS
CONFERENCES
VIDEOS
Case-Based Peer Perspectives
Expert Perspective Virtual Tumor Board
Interviews
Investigator Perspectives
Precision Medicine
PUBLICATIONS
Evolving Paradigms
Targeted Therapies in Oncology
The Journal of Targeted Therapies in Cancer
ONCAlert | Upfront Therapy for mRCC
Case Studies
Expert physicians provide insight on managing oncology-based patient cases that highlight the use of novel agents in clinical practice.
SORT BY:
A-Z
Recent
VIEW AS:
Grid
List
Lung Cancer (38)
Gynecologic Cancer (14)
Renal Cell Cancer (8)
Acute Myeloid Leukemia (6)
Multiple Myeloma (14)
Follicular Lymphoma (10)
Hepatocellular Carcinoma (11)
Cutaneous Squamous Cell Carcinoma (4)
Prostate Cancer (12)
Breast Cancer (17)
Myeloproliferative Neoplasms (14)
Chronic Lymphocytic Leukemia (12)
Colorectal Cancer (20)
Hodgkins Lymphoma (3)
non-Hodgkins Lymphoma (2)
Gastrointestinal Cancer (2)
Marginal Zone Lymphoma (2)
Pancreatic Cancer (5)
Idiopathic Thrombocytopenic Purpura (1)
Chronic Myeloid Leukemia (2)
Mantle Cell Lymphoma (2)
Gastrointestinal Stromal Tumors (2)
Melanoma (4)
Soft Tissue Sarcoma (3)
Multicentric Castleman Disease (4)
JTT Articles
Participating Practices Commend CMS for OCM Changes
The Role of Liquid Biopsy in NSCLC Continues to Emerge
Rare Incidence of ICI-Related Hepatotoxicity Frequently Ends in Treatment Discontinuation
>> View Peer-Reviewed Articles
Most Popular
Enasidenib Granted FDA's Priority Review for IDH2-Mutant AML
Novel Immunotherapy Agent ADXS-503 Plus Pembrolizumab Signals Promise in NSCLC
Genetic Profiling Suggests Rationale for Limited Response to Immunotherapy in Osteosarcoma
Polatuzumab Vedotin Plus Bendamustine/Rituximab Shows Encouraging Activity in R/R DLBCL
Publications
